Cranswick plc
Cranswick plc (CRWKF) Financial Performance & Income Statement Overview
Explore the financials of Cranswick plc (CRWKF), including yearly and quarterly data on income, cash flow, and balance sheets.
Cranswick plc (CRWKF) Income Statement & Financial Overview
Review Cranswick plc CRWKF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.39B | $1.33B | $1.35B | $1.25B |
| Cost of Revenue | $1.18B | $1.13B | $1.15B | $1.08B |
| Gross Profit | $216.50M | $203.40M | $198.10M | $174.20M |
| Gross Profit Ratio | $0.16 | $0.15 | $0.15 | $0.14 |
| R&D Expenses | $0.00 | $0.00 | $29.00M | $0.00 |
| SG&A Expenses | $108.50M | $103.80M | $103.60M | $91.10M |
| Operating Expenses | $119.90M | $109.40M | $104.20M | $91.10M |
| Total Costs & Expenses | $1.30B | $1.24B | $1.25B | $1.17B |
| Interest Income | $0.00 | $0.00 | $0.00 | $3.90M |
| Interest Expense | $5.30M | $3.90M | $5.00M | $3.90M |
| Depreciation & Amortization | $35.50M | $36.20M | $46.50M | $40.20M |
| EBITDA | $142.10M | $133.60M | $122.60M | $131.00M |
| EBITDA Ratio | $0.10 | $0.10 | $0.09 | $0.10 |
| Operating Income | $96.60M | $94.00M | $91.90M | $83.10M |
| Operating Income Ratio | $0.07 | $0.07 | $0.07 | $0.07 |
| Other Income/Expenses (Net) | -$5.20M | -$3.90M | -$20.80M | $3.80M |
| Income Before Tax | $91.40M | $90.10M | $71.10M | $86.90M |
| Income Before Tax Ratio | $0.07 | $0.07 | $0.05 | $0.07 |
| Income Tax Expense | $23.70M | $23.60M | $22.60M | $22.70M |
| Net Income | $67.70M | $66.60M | $48.90M | $64.20M |
| Net Income Ratio | $0.05 | $0.05 | $0.04 | $0.05 |
| EPS | $1.27 | $1.24 | $0.91 | $1.20 |
| Diluted EPS | $1.23 | $1.23 | $0.91 | $1.19 |
| Weighted Avg Shares Outstanding | $55.17M | $53.97M | $53.61M | $53.71M |
| Weighted Avg Shares Outstanding (Diluted) | $55.13M | $53.94M | $54.02M | $53.90M |
Financial performance has remained strong, with revenue growing from $1.25B in Q2 2023 to $1.39B in Q4 2024. Gross profit continued to perform well, with margins at 16% in the latest quarter. Operating income reached $96.60M in Q4 2024, holding a steady 7% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $142.10M. Net income rose to $67.70M, keeping EPS at $1.27. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan